The single gateway to your inhalation development

Who we are

INTO is a unique alliance in the field of inhalation development services established by DFE Pharma, Harro Höfliger and Sterling in February 2022.

Find out more about our story

What we do

Our aim is to support customers in making their respiratory product (Innovative, generics, high dose or biologic formulations) development fast, economic and easy to manage by offering our overarching view, combined expertise and coordinated approach.

Find out more about our offerings and solutions here

The single gateway to your inhalation development

API
characterization

Understanding the appropriate Active Ingredient for your product, by looking at the physical and chemical properties.

Formulation
development

Understanding the critical quality attributes,by identifying the key variables and employing risk-based strategies.

Analytical
development

Creating, optimizing, and validating analytical methods to assess product quality and performance throughout its development.

Consultancy
service

Personalized and individual inhalation consultation through all development steps.

Our Services

UPCOMING EVENTS

11th DPI China Conference

Shanghai, China
21.-22. March 2024

DCAT week

New York, USA
18.-21. March 2024

Respiratory Drug Delivery

Tucson, Arizona, USA
5.-9. May 2024

REQUEST MEETING

    The data from this contact form will be collected and processed in response to your request. The data will be deleted after your request has been processed. Note: You can revoke your consent at any time in the future by emailing to info@intoinhalation.com.
    Privacy policies: DFE Pharma / Harro Höfliger / Sterling



    Privacy Policy | Imprint